{"id":39834,"date":"2023-03-28T07:00:58","date_gmt":"2023-03-28T07:00:58","guid":{"rendered":"https:\/\/www.elza-institute.com\/?p=39834"},"modified":"2023-03-28T07:00:58","modified_gmt":"2023-03-28T07:00:58","slug":"pioneering-cxl-innovations-in-switzerland-a-look-at-the-future-of-corneal-cross-linking","status":"publish","type":"post","link":"https:\/\/www.elza-institute.com\/pt\/pioneering-cxl-innovations-in-switzerland-a-look-at-the-future-of-corneal-cross-linking\/","title":{"rendered":"Inova\u00e7\u00f5es pioneiras em CXL na Su\u00ed\u00e7a: Um olhar sobre o futuro do Cross-Linking da c\u00f3rnea"},"content":{"rendered":"<p>A Su\u00ed\u00e7a, em particular Zurique, tem sido um l\u00edder na investiga\u00e7\u00e3o e inova\u00e7\u00e3o do cross-linking da c\u00f3rnea (CXL) durante mais de duas d\u00e9cadas, explicou o Diretor M\u00e9dico da ELZA, Prof. <a href=\"https:\/\/www.elza-institute.com\/pt\/sobre\/farhad-hafezi\/\">Farhad Hafezi<\/a>MD, PhD, FARVO, na edi\u00e7\u00e3o deste m\u00eas de <a href=\"https:\/\/crstodayeurope.com\/wp-content\/uploads\/sites\/5\/2023\/02\/0123CRSTGlobal_gp_CXL.pdf\">Catarata e cirurgia refractiva hoje<\/a>.<\/p>\n<p>O contexto atual do CXL na Su\u00ed\u00e7a \u00e9 que os cirurgi\u00f5es su\u00ed\u00e7os realizam normalmente o CXL sem epit\u00e9lio (epi-off) utilizando o protocolo de Dresden ou o protocolo de CXL acelerado (A-CXL). No entanto, os recentes avan\u00e7os do grupo de investiga\u00e7\u00e3o da ELZA incluem o desenvolvimento de um protocolo de CXL epi-off ultraforte, que consegue um fortalecimento da c\u00f3rnea semelhante ao de Dresden num ter\u00e7o do tempo. Este novo protocolo utiliza irradia\u00e7\u00e3o UV com uma intensidade de 18 mW\/cm\u00b2 durante 9 minutos e 15 segundos, fornecendo uma flu\u00eancia UV de 10 J\/cm\u00b2, em compara\u00e7\u00e3o com os 5,4 J\/cm\u00b2 do protocolo de Dresden.<\/p>\n<p>Al\u00e9m disso, foi tamb\u00e9m desenvolvido pelos cirurgi\u00f5es e investigadores da ELZA um novo protocolo de CXL epi-on que n\u00e3o necessita de oxig\u00e9nio ou iontoforese para funcionar eficazmente. Este m\u00e9todo emprega uma solu\u00e7\u00e3o de riboflavina com intensificadores de penetra\u00e7\u00e3o, proporcionando efeitos de endurecimento da c\u00f3rnea semelhantes aos do CXL epi-off. Uma das vantagens do procedimento epi-on \u00e9 o facto de contornar os potenciais inconvenientes associados \u00e0 remo\u00e7\u00e3o e ao recrescimento do epit\u00e9lio. Espera-se que os dados pr\u00e9-cl\u00ednicos sobre este protocolo sejam publicados em breve.<\/p>\n<p>A <a href=\"https:\/\/www.elza-institute.com\/pt\/\">Instituto ELZA<\/a> \u00e9 tamb\u00e9m \u00fanica na posse de tr\u00eas instrumentos de avalia\u00e7\u00e3o biomec\u00e2nica da c\u00f3rnea de ponta (CorVis ST, BOSS e Elastografia OCT), que oferecem novos conhecimentos sobre o ceratocone. Al\u00e9m disso, a equipa est\u00e1 a trabalhar no aperfei\u00e7oamento do crom\u00f3foro fotoactivado para ceratite-CXL (PACK-CXL) para o tratamento da ceratite infecciosa. Descobriram que s\u00e3o necess\u00e1rias flu\u00eancias UV mais elevadas para tratar com \u00eaxito muitos casos de ceratite infecciosa.<\/p>\n<p>Os investigadores da ELZA s\u00e3o tamb\u00e9m os primeiros a avaliar o efeito combinado do PACK-CXL com rosa de bengala\/luz verde e riboflavina\/UV-A na mesma sess\u00e3o para o tratamento de doen\u00e7as f\u00fangicas recalcitrantes e de doen\u00e7as de pele. <em>Queratite por Acanthamoeba<\/em>. Estas inova\u00e7\u00f5es e descobertas no dom\u00ednio do CXL na Su\u00ed\u00e7a continuam a moldar o futuro do cross-linking corneano e a proporcionar novas vias para o tratamento de v\u00e1rias doen\u00e7as oculares.<\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/crstodayeurope.com\/wp-content\/uploads\/sites\/5\/2023\/02\/0123CRSTGlobal_gp_CXL.pdf\"><img fetchpriority=\"high\" decoding=\"async\" class=\"aligncenter wp-image-39835 size-large\" src=\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2023\/03\/pioneering-cxl-innovations-in-switzerland-795x1024.png\" alt=\"Inova\u00e7\u00f5es pioneiras em CXL na Su\u00ed\u00e7a artigo\" width=\"795\" height=\"1024\" srcset=\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2023\/03\/pioneering-cxl-innovations-in-switzerland-795x1024.png 795w, https:\/\/www.elza-institute.com\/wp-content\/uploads\/2023\/03\/pioneering-cxl-innovations-in-switzerland-233x300.png 233w, https:\/\/www.elza-institute.com\/wp-content\/uploads\/2023\/03\/pioneering-cxl-innovations-in-switzerland-768x989.png 768w, https:\/\/www.elza-institute.com\/wp-content\/uploads\/2023\/03\/pioneering-cxl-innovations-in-switzerland-9x12.png 9w, https:\/\/www.elza-institute.com\/wp-content\/uploads\/2023\/03\/pioneering-cxl-innovations-in-switzerland.png 999w\" sizes=\"(max-width: 795px) 100vw, 795px\" \/><\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Switzerland, particularly Zurich, has been a leader in corneal cross-linking (CXL) research and innovation for over two decades, explained ELZA&#8217;s Medical Director, Prof. Farhad Hafezi, MD, PhD, FARVO, in this month&#8217;s issue of Cataract and Refractive Surgery Today. The current context of CXL in Switzerland is that Swiss surgeons typically perform epithelium-off (epi-off) CXL using [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":39838,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[214,96],"tags":[209,132,130,100,134,123,122],"class_list":["post-39834","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-farhad-hafezi","category-popular-press","tag-basic-research","tag-biomechanics","tag-cross-linking","tag-cxl","tag-epi-on","tag-keratoconus","tag-translational-research"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pioneering CXL Innovations in Switzerland: A Look at the Future of Corneal Cross-Linking - The ELZA Institute<\/title>\n<meta name=\"description\" content=\"Discover the latest CXL innovations in Switzerland, including ultrastrong epi-off CXL and epi-on CXL without oxygen.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.elza-institute.com\/pt\/pioneering-cxl-innovations-in-switzerland-a-look-at-the-future-of-corneal-cross-linking\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pioneering CXL Innovations in Switzerland: A Look at the Future of Corneal Cross-Linking - The ELZA Institute\" \/>\n<meta property=\"og:description\" content=\"Discover the latest CXL innovations in Switzerland, including ultrastrong epi-off CXL and epi-on CXL without oxygen.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.elza-institute.com\/pt\/pioneering-cxl-innovations-in-switzerland-a-look-at-the-future-of-corneal-cross-linking\/\" \/>\n<meta property=\"og:site_name\" content=\"The ELZA Institute\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ELZA.Institute\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-28T07:00:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2023\/03\/CAL-in-Switzerland.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Prof. Farhad Hafezi\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Prof. Farhad Hafezi\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.elza-institute.com\/pioneering-cxl-innovations-in-switzerland-a-look-at-the-future-of-corneal-cross-linking\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.elza-institute.com\/pioneering-cxl-innovations-in-switzerland-a-look-at-the-future-of-corneal-cross-linking\/\"},\"author\":{\"name\":\"Prof. Farhad Hafezi\",\"@id\":\"https:\/\/www.elza-institute.com\/#\/schema\/person\/fe18c29daf39386a63981ffe5627ee2c\"},\"headline\":\"Pioneering CXL Innovations in Switzerland: A Look at the Future of Corneal Cross-Linking\",\"datePublished\":\"2023-03-28T07:00:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.elza-institute.com\/pioneering-cxl-innovations-in-switzerland-a-look-at-the-future-of-corneal-cross-linking\/\"},\"wordCount\":330,\"publisher\":{\"@id\":\"https:\/\/www.elza-institute.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.elza-institute.com\/pioneering-cxl-innovations-in-switzerland-a-look-at-the-future-of-corneal-cross-linking\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2023\/03\/CAL-in-Switzerland.png\",\"keywords\":[\"Basic Research\",\"Biomechanics\",\"Cross-Linking\",\"CXL\",\"epi-on\",\"Keratoconus\",\"Translational Research\"],\"articleSection\":[\"Farhad Hafezi\",\"Popular press\"],\"inLanguage\":\"pt-PT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.elza-institute.com\/pioneering-cxl-innovations-in-switzerland-a-look-at-the-future-of-corneal-cross-linking\/\",\"url\":\"https:\/\/www.elza-institute.com\/pioneering-cxl-innovations-in-switzerland-a-look-at-the-future-of-corneal-cross-linking\/\",\"name\":\"Pioneering CXL Innovations in Switzerland: A Look at the Future of Corneal Cross-Linking - The ELZA Institute\",\"isPartOf\":{\"@id\":\"https:\/\/www.elza-institute.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.elza-institute.com\/pioneering-cxl-innovations-in-switzerland-a-look-at-the-future-of-corneal-cross-linking\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.elza-institute.com\/pioneering-cxl-innovations-in-switzerland-a-look-at-the-future-of-corneal-cross-linking\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2023\/03\/CAL-in-Switzerland.png\",\"datePublished\":\"2023-03-28T07:00:58+00:00\",\"description\":\"Discover the latest CXL innovations in Switzerland, including ultrastrong epi-off CXL and epi-on CXL without oxygen.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.elza-institute.com\/pioneering-cxl-innovations-in-switzerland-a-look-at-the-future-of-corneal-cross-linking\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.elza-institute.com\/pioneering-cxl-innovations-in-switzerland-a-look-at-the-future-of-corneal-cross-linking\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\/\/www.elza-institute.com\/pioneering-cxl-innovations-in-switzerland-a-look-at-the-future-of-corneal-cross-linking\/#primaryimage\",\"url\":\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2023\/03\/CAL-in-Switzerland.png\",\"contentUrl\":\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2023\/03\/CAL-in-Switzerland.png\",\"width\":1200,\"height\":600,\"caption\":\"CXL-in-Switzerland\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.elza-institute.com\/pioneering-cxl-innovations-in-switzerland-a-look-at-the-future-of-corneal-cross-linking\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.elza-institute.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Farhad Hafezi\",\"item\":\"https:\/\/www.elza-institute.com\/farhad-hafezi\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Pioneering CXL Innovations in Switzerland: A Look at the Future of Corneal Cross-Linking\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.elza-institute.com\/#website\",\"url\":\"https:\/\/www.elza-institute.com\/\",\"name\":\"The ELZA Institute\",\"description\":\"Swiss EyeCare at its finest\",\"publisher\":{\"@id\":\"https:\/\/www.elza-institute.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.elza-institute.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.elza-institute.com\/#organization\",\"name\":\"The ELZA Institute\",\"url\":\"https:\/\/www.elza-institute.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\/\/www.elza-institute.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2016\/04\/ELZA-logo-V4.jpg\",\"contentUrl\":\"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2016\/04\/ELZA-logo-V4.jpg\",\"width\":1181,\"height\":453,\"caption\":\"The ELZA Institute\"},\"image\":{\"@id\":\"https:\/\/www.elza-institute.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/ELZA.Institute\/\",\"https:\/\/x.com\/ELZA_Institute\",\"https:\/\/www.linkedin.com\/company\/elza-institute?trk=top_nav_home\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.elza-institute.com\/#\/schema\/person\/fe18c29daf39386a63981ffe5627ee2c\",\"name\":\"Prof. Farhad Hafezi\",\"url\":\"https:\/\/www.elza-institute.com\/pt\/author\/adminelza-institute-com\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Inova\u00e7\u00f5es pioneiras em CXL na Su\u00ed\u00e7a: Um olhar sobre o futuro do Cross-Linking da c\u00f3rnea - Instituto ELZA","description":"Descubra as mais recentes inova\u00e7\u00f5es em CXL na Su\u00ed\u00e7a, incluindo o CXL epi-off ultraforte e o CXL epi-on sem oxig\u00e9nio.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.elza-institute.com\/pt\/pioneering-cxl-innovations-in-switzerland-a-look-at-the-future-of-corneal-cross-linking\/","og_locale":"pt_PT","og_type":"article","og_title":"Pioneering CXL Innovations in Switzerland: A Look at the Future of Corneal Cross-Linking - The ELZA Institute","og_description":"Discover the latest CXL innovations in Switzerland, including ultrastrong epi-off CXL and epi-on CXL without oxygen.","og_url":"https:\/\/www.elza-institute.com\/pt\/pioneering-cxl-innovations-in-switzerland-a-look-at-the-future-of-corneal-cross-linking\/","og_site_name":"The ELZA Institute","article_publisher":"https:\/\/www.facebook.com\/ELZA.Institute\/","article_published_time":"2023-03-28T07:00:58+00:00","og_image":[{"width":1200,"height":600,"url":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2023\/03\/CAL-in-Switzerland.png","type":"image\/png"}],"author":"Prof. Farhad Hafezi","twitter_misc":{"Escrito por":"Prof. Farhad Hafezi","Tempo estimado de leitura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.elza-institute.com\/pioneering-cxl-innovations-in-switzerland-a-look-at-the-future-of-corneal-cross-linking\/#article","isPartOf":{"@id":"https:\/\/www.elza-institute.com\/pioneering-cxl-innovations-in-switzerland-a-look-at-the-future-of-corneal-cross-linking\/"},"author":{"name":"Prof. Farhad Hafezi","@id":"https:\/\/www.elza-institute.com\/#\/schema\/person\/fe18c29daf39386a63981ffe5627ee2c"},"headline":"Pioneering CXL Innovations in Switzerland: A Look at the Future of Corneal Cross-Linking","datePublished":"2023-03-28T07:00:58+00:00","mainEntityOfPage":{"@id":"https:\/\/www.elza-institute.com\/pioneering-cxl-innovations-in-switzerland-a-look-at-the-future-of-corneal-cross-linking\/"},"wordCount":330,"publisher":{"@id":"https:\/\/www.elza-institute.com\/#organization"},"image":{"@id":"https:\/\/www.elza-institute.com\/pioneering-cxl-innovations-in-switzerland-a-look-at-the-future-of-corneal-cross-linking\/#primaryimage"},"thumbnailUrl":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2023\/03\/CAL-in-Switzerland.png","keywords":["Basic Research","Biomechanics","Cross-Linking","CXL","epi-on","Keratoconus","Translational Research"],"articleSection":["Farhad Hafezi","Popular press"],"inLanguage":"pt-PT"},{"@type":"WebPage","@id":"https:\/\/www.elza-institute.com\/pioneering-cxl-innovations-in-switzerland-a-look-at-the-future-of-corneal-cross-linking\/","url":"https:\/\/www.elza-institute.com\/pioneering-cxl-innovations-in-switzerland-a-look-at-the-future-of-corneal-cross-linking\/","name":"Inova\u00e7\u00f5es pioneiras em CXL na Su\u00ed\u00e7a: Um olhar sobre o futuro do Cross-Linking da c\u00f3rnea - Instituto ELZA","isPartOf":{"@id":"https:\/\/www.elza-institute.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.elza-institute.com\/pioneering-cxl-innovations-in-switzerland-a-look-at-the-future-of-corneal-cross-linking\/#primaryimage"},"image":{"@id":"https:\/\/www.elza-institute.com\/pioneering-cxl-innovations-in-switzerland-a-look-at-the-future-of-corneal-cross-linking\/#primaryimage"},"thumbnailUrl":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2023\/03\/CAL-in-Switzerland.png","datePublished":"2023-03-28T07:00:58+00:00","description":"Descubra as mais recentes inova\u00e7\u00f5es em CXL na Su\u00ed\u00e7a, incluindo o CXL epi-off ultraforte e o CXL epi-on sem oxig\u00e9nio.","breadcrumb":{"@id":"https:\/\/www.elza-institute.com\/pioneering-cxl-innovations-in-switzerland-a-look-at-the-future-of-corneal-cross-linking\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.elza-institute.com\/pioneering-cxl-innovations-in-switzerland-a-look-at-the-future-of-corneal-cross-linking\/"]}]},{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/www.elza-institute.com\/pioneering-cxl-innovations-in-switzerland-a-look-at-the-future-of-corneal-cross-linking\/#primaryimage","url":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2023\/03\/CAL-in-Switzerland.png","contentUrl":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2023\/03\/CAL-in-Switzerland.png","width":1200,"height":600,"caption":"CXL-in-Switzerland"},{"@type":"BreadcrumbList","@id":"https:\/\/www.elza-institute.com\/pioneering-cxl-innovations-in-switzerland-a-look-at-the-future-of-corneal-cross-linking\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.elza-institute.com\/"},{"@type":"ListItem","position":2,"name":"Farhad Hafezi","item":"https:\/\/www.elza-institute.com\/farhad-hafezi\/"},{"@type":"ListItem","position":3,"name":"Pioneering CXL Innovations in Switzerland: A Look at the Future of Corneal Cross-Linking"}]},{"@type":"WebSite","@id":"https:\/\/www.elza-institute.com\/#website","url":"https:\/\/www.elza-institute.com\/","name":"O Instituto ELZA","description":"Swiss EyeCare no seu melhor","publisher":{"@id":"https:\/\/www.elza-institute.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.elza-institute.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Organization","@id":"https:\/\/www.elza-institute.com\/#organization","name":"O Instituto ELZA","url":"https:\/\/www.elza-institute.com\/","logo":{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/www.elza-institute.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2016\/04\/ELZA-logo-V4.jpg","contentUrl":"https:\/\/www.elza-institute.com\/wp-content\/uploads\/2016\/04\/ELZA-logo-V4.jpg","width":1181,"height":453,"caption":"The ELZA Institute"},"image":{"@id":"https:\/\/www.elza-institute.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ELZA.Institute\/","https:\/\/x.com\/ELZA_Institute","https:\/\/www.linkedin.com\/company\/elza-institute?trk=top_nav_home"]},{"@type":"Person","@id":"https:\/\/www.elza-institute.com\/#\/schema\/person\/fe18c29daf39386a63981ffe5627ee2c","name":"Prof. Farhad Hafezi","url":"https:\/\/www.elza-institute.com\/pt\/author\/adminelza-institute-com\/"}]}},"_links":{"self":[{"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/posts\/39834","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/comments?post=39834"}],"version-history":[{"count":0,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/posts\/39834\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/media\/39838"}],"wp:attachment":[{"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/media?parent=39834"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/categories?post=39834"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.elza-institute.com\/pt\/wp-json\/wp\/v2\/tags?post=39834"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}